PubMed Health⌕ Search

Biomedical subjects

H Starkman

Publications and source records attributed to H Starkman.

4 recordsLinked to original sources

Biochemical studies of a patient with hereditary hepatorenal tyrosinemia: evidence of glutathione deficiency.

Metabolic and enzymatic studies in a patient with hereditary tyrosinemia demonstrated for the first time a deficiency of erythrocyte and hepatic glutathione. Markedly decreased hepatic fumarylacetoacetate hydrolase activity was demonstrated in this patient. The activities of hepatic enzymes not involved in tyrosine metabolism were also determined. Assay of mixed function oxidase activity demonstrated low levels of aryl hydrocarbon hydroxylase and 7-ethoxycoumarin deethylase, suggesting decreased hepatic detoxification capacity. 5-Aminolevulinic acid dehydratase activity was undetectable. Succinylacetone (4,6-dioxoheptanoic acid), an abnormal metabolic product secondary to fumarylacetoacetate hydrolase deficiency was found in serum and urine. Succinylacetone was demonstrated to inhibit 5-aminolevulinic acid dehydratase in vitro, as did the urine, plasma, and red cell lysates of the patient.

Erythrocytes↗

Acute L-thyroxine overdose; therapy with sodium ipodate: evaluation of clinical and physiologic parameters.

Two children with acute L-thyroxine overdose were treated with sodium ipodate, an oral cholecystographic agent. Initial thyroxine (T4) levels were elevated to 98.5 mcg/dL and 134.1 mcg/dL, with associated triiodothyroxine (T3) levels of 354 ng/dL and 402 ng/dL. T3 levels increased to a maximum of 662 ng/dL and 468 ng/dL. With administration of sodium ipodate, the T3 decreased with a simultaneous increase of rT3 level. Sodium ipodate effect lasted 72 hours. No toxic effect was noted. Interestingly, thyroid hormone levels correlated with systolic blood pressure but with no other physiologic parameter. Sodium ipodate appears to be a viable treatment modality for acute thyroid overdose in children.

Acute Disease↗

Limited joint mobility of the hand in type I diabetes mellitus.

Limited joint mobility (LJM) of the hand was present in 32 of 100 subjects, aged 3-22 yr, with type I diabetes mellitus. Prevalence of LJM was independent of age and sex, but increased with duration of diabetes, with peak occurrence in individuals who had diabetes for more than 5 yr (P less than 0.005). In age-and duration-matched pairs of control and LJM subjects (N = 31), there was no significant correlation of LJM with insulin type, insulin allergy, family history of arthritis, or growth retardation. There was also no correlation with "control parameters" including number of episodes of hypoglycemia and ketoacidosis, degree of ketonuria or mean glucose, hemoglobin A1, fasting triglyceride, or cholesterol value.

Adolescent↗